利伐沙班与华法林或达比加群用于房颤导管消融患者的比较：一项荟萃分析。 - Suppr

Suppr

超能文献

Rivaroxaban versus warfarin or dabigatran in patients undergoing catheter ablation for atrial fibrillation: A meta-analysis.

作者信息

Phan Kevin, Wang Nelson, Pison Laurent, Kumar Narendra, Hitos Kerry, Thomas Stuart P

机构信息

Department of Cardiology, Westmead Hospital, Sydney, Australia.

University of Sydney, Sydney, Australia.

出版信息

Int J Cardiol. 2015 Apr 15;185:209-13. doi: 10.1016/j.ijcard.2015.03.102. Epub 2015 Mar 10.

DOI:10.1016/j.ijcard.2015.03.102

PMID:25797679

Abstract

摘要

相似文献

Rivaroxaban versus warfarin or dabigatran in patients undergoing catheter ablation for atrial fibrillation: A meta-analysis.

Int J Cardiol. 2015 Apr 15;185:209-13. doi: 10.1016/j.ijcard.2015.03.102. Epub 2015 Mar 10.

Comparison of the short-term risk of bleeding and arterial thromboembolic events in nonvalvular atrial fibrillation patients newly treated with dabigatran or rivaroxaban versus vitamin K antagonists: a French nationwide propensity-matched cohort study.

Circulation. 2015 Sep 29;132(13):1252-60. doi: 10.1161/CIRCULATIONAHA.115.015710. Epub 2015 Jul 21.

Meta-analysis of efficacy and safety of rivaroxaban compared with warfarin or dabigatran in patients undergoing catheter ablation for atrial fibrillation.

Am J Cardiol. 2014 Aug 15;114(4):577-82. doi: 10.1016/j.amjcard.2014.05.038. Epub 2014 Jun 6.

Periprocedural Management of New Oral Anticoagulants in Atrial Fibrillation Ablation.

J Cardiovasc Pharmacol Ther. 2015 Sep;20(5):457-64. doi: 10.1177/1074248415576193. Epub 2015 Mar 31.

Thromboembolic, Bleeding, and Mortality Risks of Rivaroxaban and Dabigatran in Asians With Nonvalvular Atrial Fibrillation.

J Am Coll Cardiol. 2016 Sep 27;68(13):1389-1401. doi: 10.1016/j.jacc.2016.06.062.

Safety of dabigatran or rivaroxaban for thoracoscopic ablation in patients with atrial fibrillation.

Int J Cardiol. 2015;186:213-5. doi: 10.1016/j.ijcard.2015.03.229. Epub 2015 Mar 18.

Safety of new oral anticoagulants for patients undergoing atrial fibrillation ablation.

J Interv Card Electrophysiol. 2014 Jun;40(1):33-8. doi: 10.1007/s10840-014-9888-9. Epub 2014 Mar 19.

Efficacy and safety of rivaroxaban compared with vitamin K antagonists for peri-procedural anticoagulation in catheter ablation of atrial fibrillation: a systematic review and meta-analysis.

Europace. 2016 Dec;18(12):1787-1794. doi: 10.1093/europace/euv408. Epub 2016 Jan 20.

Rivaroxaban in atrial fibrillation cardioversion: insights from the X-VeRT trial.

Future Cardiol. 2015 Mar;11(2):147-51. doi: 10.2217/fca.15.4.

[Factors Associated with Direct Oral Anticoagulants versus Vitamin K Antagonists in Patients with Non-valvular Atrial Fibrillation].

Therapie. 2015 Nov-Dec;70(6):485-92. doi: 10.2515/therapie/2015032. Epub 2015 Jul 29.

引用本文的文献

UBLED AF (Uninterrupted BLackpool EDoxaban vs Warfarin vs Rivaroxaban in Atrial Fibrillation/Flutter ablation) Study.

J Atr Fibrillation. 2021 Aug 31;14(2):20200445. doi: 10.4022/jafib.20200445. eCollection 2021 Aug.

Uninterrupted administration of edoxaban vs vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation: Rationale and design of the ELIMINATE-AF study.

Clin Cardiol. 2018 Apr;41(4):440-449. doi: 10.1002/clc.22918. Epub 2018 Apr 17.

Periprocedural Management of Direct Oral Anticoagulants Surrounding Cardioversion and Invasive Electrophysiological Procedures.

Cardiol Rev. 2018 Sep/Oct;26(5):245-254. doi: 10.1097/CRD.0000000000000188.

Periprocedural Anticoagulation Management for Atrial Fibrillation Ablation: Current Knowledge and Future Directions.

Curr Treat Options Cardiovasc Med. 2018 Jan 25;20(1):3. doi: 10.1007/s11936-018-0600-8.

2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.

Europace. 2018 Jan 1;20(1):e1-e160. doi: 10.1093/europace/eux274.

2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.

Heart Rhythm. 2017 Oct;14(10):e275-e444. doi: 10.1016/j.hrthm.2017.05.012. Epub 2017 May 12.

Are Some Anticoagulants More Equal Than Others? - Evaluating the Role of Novel Oral Anticoagulants in AF Ablation.

Curr Cardiol Rev. 2016;12(4):330-335. doi: 10.2174/1573403x12666160505113755.

Network meta-analysis of efficacy and safety of competitive oral anticoagulants in patients undergoing radiofrequency catheter ablation of atrial fibrillation.

J Interv Card Electrophysiol. 2016 Sep;46(3):213-24. doi: 10.1007/s10840-016-0126-5. Epub 2016 Mar 21.

Efficacy and safety of rivaroxaban compared with vitamin K antagonists for peri-procedural anticoagulation in catheter ablation of atrial fibrillation: a systematic review and meta-analysis.

Europace. 2016 Dec;18(12):1787-1794. doi: 10.1093/europace/euv408. Epub 2016 Jan 20.

2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society.

Heart Rhythm. 2012 Apr;9(4):632-696.e21. doi: 10.1016/j.hrthm.2011.12.016. Epub 2012 Mar 1.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验